Collectively, these data indicated that treatment with 5-ALA enhanced ultrasound-mediated inhibition of BcL-2 expression, but increased ultrasound-up-regulated Bax, p53 and caspase 3 expression in the implanted osteosarcoma in mice. The gene discussed is BCL2; the disease is osteosarcoma.